AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
Mona Ashiya is a General Partner at OrbiMed and has been with the firm since 2010. She focuses on life sciences venture capital and special situations opportunities, and OrbiMed has said she led investments including Sierra Oncology, Disc Medicine and ProfoundBio. Before OrbiMed, she covered biotechnology at J.P. Morgan and held roles at the Global Alliance for TB Drug Development and Harvard Business School.
Notable companies
Selected portfolio companies the partner has backed
Sierra OncologyDisc MedicineProfoundBioShattuck Labs
Background
Career, education, and skills
Career history
- OrbiMedGeneral Partner2025 – Present
- OrbiMedMember / Partner2010 – 2025
- J.P. MorganBiotechnology equity research
- Global Alliance for TB Drug DevelopmentPosition
- Harvard Business SchoolPosition
Education
- University of California at BerkeleyB.A.
- University of PittsburghPh.D. in Cellular, Molecular, and Developmental Biology
- Dana-Farber Cancer InstitutePost-doctoral fellowship
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.